Cornerstone Planning Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.8K Buy
413
+11
+3% +$921 ﹤0.01% 494
2026
Q1
$33.3K Buy
402
+69
+21% +$5.69K ﹤0.01% 509
2025
Q4
$27.3K Buy
333
+11
+3% +$903 ﹤0.01% 508
2025
Q3
$26.9K Buy
322
+15
+5% +$1.17K ﹤0.01% 492
2025
Q2
$24.3K Buy
307
+16
+5% +$1.19K 0.01% 377
2025
Q1
$20.5K Buy
291
+28
+11% +$2K ﹤0.01% 406
2024
Q4
$18.2K Buy
263
+7
+3% +$490 ﹤0.01% 322
2024
Q3
$17.8K Buy
256
+32
+14% +$2.33K ﹤0.01% 312
2024
Q2
$13.6K Buy
+224
New +$19.8K ﹤0.01% 377

Other funds holding EW

Cornerstone Planning Group's EW Position: Q2 2026 in Review

Cornerstone Planning Group increased its Edwards Lifesciences (EW) stake by 2.7% in Q2 2026, buying an estimated $921 and bringing the position to 413 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

Cornerstone Planning Group first reported a position in EW in Q2 2024 and has held it in 9 quarters since. 833 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Cornerstone Planning Group held 413 shares of Edwards Lifesciences worth $34.8K as of Q2 2026.
  • Cornerstone Planning Group bought 11 Edwards Lifesciences shares in Q2 2026, an estimated $921.
  • Edwards Lifesciences made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #494 holding.
  • Cornerstone Planning Group first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 9 quarters since.
  • 833 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.